Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Dow
McKesson
UBS
Baxter
Covington
Johnson and Johnson
Farmers Insurance

Generated: May 20, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FLUTICASONE FUROATE

« Back to Dashboard

Clinical Trials for fluticasone furoate

Trial ID Title Status Sponsor Phase Summary
NCT00000577 Asthma Clinical Research Network (ACRN) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000622 Childhood Asthma Research and Education (CARE) Network Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 The purpose of this study is to evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.
NCT00071552 Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients Terminated Teva Branded Pharmaceutical Products, R&D Inc. Phase 4 The primary objective of this study is to evaluate the effect of Beclomethasone dipropionate HFA on small airways compared to Fluticasone propionate powder for inhalation administered twice daily to poorly controlled asthmatics.
NCT00102765 Study Of Asthma In Patients Of African Descent Completed GlaxoSmithKline Phase 4 This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic visits will include physical examination, medical history review and lung function tests. The purpose of this study is to see if one asthma drug (fluticasone propionate/salmeterol) is better in reducing the number of asthma exacerbations compared with another drug (fluticasone propionate alone)
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for fluticasone furoate

Condition Name

Condition Name for fluticasone furoate
Intervention Trials
Asthma 242
Pulmonary Disease, Chronic Obstructive 78
Chronic Obstructive Pulmonary Disease 33
Seasonal Allergic Rhinitis 30
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for fluticasone furoate
Intervention Trials
Asthma 204
Pulmonary Disease, Chronic Obstructive 137
Lung Diseases 135
Rhinitis, Allergic 103
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for fluticasone furoate

Trials by Country

Trials by Country for fluticasone furoate
Location Trials
Germany 369
Australia 93
Mexico 87
Chile 75
Spain 64
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for fluticasone furoate
Location Trials
California 121
Texas 112
Florida 106
South Carolina 103
North Carolina 98
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for fluticasone furoate

Clinical Trial Phase

Clinical Trial Phase for fluticasone furoate
Clinical Trial Phase Trials
Phase 4 170
Phase 3 195
Phase 2/Phase 3 4
[disabled in preview] 84
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for fluticasone furoate
Clinical Trial Phase Trials
Completed 451
Recruiting 41
Terminated 23
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for fluticasone furoate

Sponsor Name

Sponsor Name for fluticasone furoate
Sponsor Trials
GlaxoSmithKline 244
Merck Sharp & Dohme Corp. 60
Novartis Pharmaceuticals 20
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for fluticasone furoate
Sponsor Trials
Industry 527
Other 207
NIH 13
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Fish and Richardson
Medtronic
Express Scripts
Accenture
Dow
QuintilesIMS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.